Simcere Pharmaceutical files board, committee member list with disclosure responsibilities

• Simcere set out its board and committee memberships in an Aug. 20, 2026 filing.
• Ren Jinsheng remains chairman, chief executive, strategy committee chair; also sits on remuneration and nomination committees.
• Board includes executive directors Wan Yushan, Wang Xi; non-executive director Tang Renhong; four independent non-executive directors.
• Independent directors lead key oversight: Wang Xinhua chairs audit; Wang Jianguo chairs remuneration; Song Ruilin chairs nomination.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simcere Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260820-12293400), on August 20, 2026, and is solely responsible for the information contained therein.